DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
$41,007,134N01FY2020CANIH
Leidos Biomedical Research, Inc., Frederick MD
Investigators
Abstract
Development and delivery of molecular characterization methods for newly identified cancer biomarkers.
View original record on NIH RePORTER →